Sio Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Sio Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-91,362	Closed	-$2.42M	–	80
2021 Q4	$2.42M	Hold	91,362	–	–	0.73%	38
2021 Q3	$3.32M	Buy	91,362 +8,390	+10%	+$330K	1.06%	30
2021 Q2	$3.6M	Buy	+82,972	New	+$3.13M	0.9%	41
2019 Q2	–	Sell	-160,927	Closed	-$4.14M	–	83
2019 Q1	$4.14M	Sell	160,927 -57,128	-26%	-$1.31M	1.12%	35
2018 Q4	$5.01M	Buy	218,055 +33,705	+18%	+$951K	1.83%	19
2018 Q3	$5.92M	Buy	184,350 +44,488	+32%	+$1.34M	2.03%	20
2018 Q2	$3.96M	Buy	+139,862	New	+$4.98M	2.19%	16
2018 Q1	–	Sell	-88,506	Closed	-$3.43M	–	44
2017 Q4	$3.43M	Sell	88,506 -67,825	-43%	-$2.58M	1.94%	20
2017 Q3	$3.97M	Buy	156,331 +21,759	+16%	+$529K	2.06%	16
2017 Q2	$3.67M	Sell	134,572 -54,246	-29%	-$1.48M	1.75%	24
2017 Q1	$6.25M	Buy	188,818 +62,479	+49%	+$1.59M	3.5%	8
2016 Q4	$3.01M	Buy	126,339 +24,267	+24%	+$695K	1.75%	24
2016 Q3	$3.75M	Sell	102,072 -31,298	-23%	-$897K	2.58%	11
2016 Q2	$2.97M	Sell	133,370 -28,320	-18%	-$704K	1.52%	21
2016 Q1	$3.36M	Buy	+161,690	New	+$3.99M	1.23%	29

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sio Capital Management's RIGL Position: Q1 2022 in Review

Sio Capital Management sold out of Rigel Pharmaceuticals (RIGL) in Q1 2022, closing a stake of 91,362 shares — an estimated $2.42M sold.

Sio Capital Management first reported a position in RIGL in Q1 2016 and held it in 15 quarters. The position peaked at $6.25M in Q1 2017. 164 funds tracked by Wall St. Rank hold RIGL as of Q1 2022.

Sio Capital Management reported no remaining Rigel Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Sio Capital Management sold 91,362 Rigel Pharmaceuticals shares in Q1 2022, an estimated $2.42M.
Sio Capital Management first reported a position in Rigel Pharmaceuticals in Q1 2016 and held it in 15 quarters.
Sio Capital Management's Rigel Pharmaceuticals position peaked at $6.25M in Q1 2017.
164 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2022.

Based on Sio Capital Management's 13F filing for Q1 2022, filed 16 May 2022.